期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脑尿钠肽在充血性心力衰竭以外的一些疾病中的研究进展 被引量：2

Research Progress of Brain Natriuretic Peptide in the Diseases Excluding Congestive Heart Failure
下载PDF
导出
摘要 脑尿钠肽被公认为是心力衰竭的重要标志物,在心力衰竭的诊断、治疗和预后评估中发挥着重要作用。但随着对脑尿钠肽研究的深入,人们发现脑尿钠肽在其它一些疾病中(如急性冠状动脉综合征、心律失常、肺部疾病、肾脏疾病等)也有不同程度的升高,并有其相应的变化规律和临床意义。在这里我们就脑尿钠肽在充血性心力衰竭外的这些疾病中的研究进展作简单综述,以更全面理解脑尿钠肽的变化规律,更好使用脑尿钠肽指导临床治疗。 Brain natriuretic peptide is considered to be an important marker of heart failure.It plays an important role in the diagnosis,treatment and prognosis of the heart failure.However,more researches of brain natriuretic peptide display that it increases in some other diseases（such as acute coronary syndrome,arrhythmia,pulmonary diseases and kidney disease etc）too,with corresponding changes and clinical significance.In this paper we review the research progress of brain natriuretic peptide in some other diseases excluding congestive heart failure,in order to understand brain natriuretic peptide better and guide the clinical treatment.
作者 李鹏飞 张丹
机构地区 重庆医科大学附属第一医院急诊科
出处 《心血管病学进展》 CAS 2011年第6期866-869,共4页 Advances in Cardiovascular Diseases
关键词 脑尿钠肽 非充血性心力衰竭疾病 急性冠状动脉综合征 心律失常 肺部疾病 肾脏疾病 brain natriuretic peptide congestive heart failure acute coronary syndrome arrhythmia pulmonary diseases kidney disease
分类号 R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献27

  • 1Taub PR,Gabbai-Saldate P,Maisel A.Biomarkers of heart faihre[J].Congest Heart Fail,2010,16 suppl 1(4):S19-S24.
  • 2Kuwahara K,Nakao K.Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones[J].Endocr J,2010,57(7):555-565.
  • 3Nishikimi T,Minamino N,Masashi Ⅰ,et al.Diversity of molecular forms of plasma brain natriuretic peptide in heart failure-different proBNP-108 to BNP32 ratios in atrial and ventricular overload[J].Heart,2010,96(6):432-439.
  • 4Dhar S,Pressman GS,Subramanian S,et al.Natriuretic peptides and heart failure in the parent with chronic kidney disease:a review of current evidence[J].Postgrad Med J,2009,85(1004):299-302.
  • 5Krupicka J,Janota T,Kasalová Z,et al.Natriuretic peptides-physiology,pathophysiology and clinical use in heart failure[J].Physiol Res,2009,58(2):171-177.
  • 6Jessup M,Abraham WT,Casey DE,et al.2009 focused update:ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults:a report of the.American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the International Society for Heart and Lung Transplantation[J].Circulation,2009,119(14):1977-2016.
  • 7Januzzi JL,van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients:The Intematioaal Collaborative of NTproBNP Study[J].Eur Heart J,2006,27(3):330-337.
  • 8Nishiyama K,Tsutamoto T,Tanaka T,et al.Plasma NT-proBNP as a more reliable biomarker of endogenous cardiac natriuretic peptides than BNP during carperitide infusion[J].Int Heart J,2009,50(2):183-190.
  • 9Wang TJ,Larson MG,Levy D.Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J].N Engl J Med,2004,39(6):1357.
  • 10Palazzuoli A,Maisel A,Caputo M,et al.B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function[J].Regul Pept,2011,167(1):129-133.

二级参考文献9

  • 1吴学明,左志通,陈艳红.血浆脑利钠肽浓度与心室重构的关系[J].中国微循环,2007,11(3):195-197. 被引量：8
  • 2Hildebrandt P.Natriuretic peptides:prediction of cardiovascular disease in the general population and high risk populations[J].Dis Markers,2009,26(5-6):227.
  • 3Austin WJ,Bhalla V,Hernandez-Arce I,et al.Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease[J].Am J Clin Pathol,2006,126(4):506.
  • 4van Kimmenade RR,Januzzi JL Jr,Baggish AL,et al.Amino-terminal pro-brain natriuretic Peptide,renal function,and outcomes in acute heart failure:redefining the cardiorenal interaction[J]? J Am Coll Cardiol,2006,48(8):1621.
  • 5Tagore R,Ling LH,Yang H,et al.Natriuretic peptides in chronic kidney disease[J].Clin J Am Soc Nephrol,2008,3(6):1644.
  • 6van Kimmenade RR,Januzzi JL Jr,Bakker JA,et al.Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects[J].J Am Coll Cardiol,2009,53(10):884.
  • 7Januzzi JL Jr.CamargoCA,Anwaruddin Sm et al.The N-terminal pro-BNP investigation of dyspneainthe emergency department(PRIDE) study[J].Am J Cardiol,2005,95(8):948.
  • 8Goei D,Schouten O,Boersma E,et al.Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery[J].Am J Cardiol,2008,101(1):122.
  • 9修亦斌,郭汉城,王卫星,王挹青.不同肾小球滤过率评估方程在慢性肾脏病患者中适用性的比较[J].中国中西医结合肾病杂志,2009,10(6):530-532. 被引量：7

共引文献12

同被引文献16

  • 1吴终慧,雷招宝.伊曲康唑的不良反应[J].药物不良反应杂志,2004,6(3):166-169. 被引量：10
  • 2顾伟,李春盛,潘世芬,何新华.危重病患者心肌肌钙蛋白Ⅰ测定的临床意义[J].中国急救医学,2004,24(11):784-786. 被引量：23
  • 3朱利平,翁心华.伊曲康唑在侵袭性真菌感染中的预防作用[J].中国新药与临床杂志,2006,25(11):805-808. 被引量：6
  • 4Thomas M,Guest,Anand V. Myocardial injury in critically ill patients,a frequently unrecognized complication[J].Journal of the American Medical Association,1995,(24):1945-1949.
  • 5Galvani M,Dttami F,Oltrona L. N-terminal pro-brain natriureti peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes[J].Circulation,2004,(01):128-134.
  • 6John J,Woodward DB,Wang Y. Troponin T as a prognosticator of mortality in severe sepsis patients[J].Journal of Critical Care,2010,(02):270-275.
  • 7Arlati S,Brenna S,Prencipe L. Myocardial necrosis in ICU patients with acute non-cardial disease:a prospective study[J].Intensive Care Medicine,2000,(01):31-37.doi:10.1007/s001340050008.
  • 8Kuwahara K,Nakao K. Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones[J].Endocrine Journal,2010,(07):555-565.
  • 9Ishii J,Cui W,Kitagawa F. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure[J].Clinical Chemistry,2003,(12):2020-2026.doi:10.1373/clinchem.2003.021311.
  • 10Chen HH,Burnett JC. Natriuretic peptides in pathophysiogy of congestive heart failure[J].Current Cardiology Reports,2000,(02):198-205.

引证文献2

二级引证文献10

心血管病学进展
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部